Edouard Fu, PhD student at the Department of Clinical Epidemiology at the LUMC, uses big data to study the effectiveness and safety of kidney, diabetes and heart failure treatments. With a Rubicon grant from NWO, Edouard will conduct further research at Harvard Medical School over the next two years.
In the first round of Rubicon 2021, a total of 24 newly graduated scientists were selected to conduct research abroad at prestigious institutions such as Oxford and Harvard.
Wonder drugs for diabetics?
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new group of medications used for treating patients with type 2 diabetes, kidney disease, or heart failure. The potential impact of this novel medication class is enormous: type 2 diabetes currently affects more than 400 million people worldwide, whereas heart failure is the leading cause of hospitalizations in the Western world.
Considered a breakthrough in the treatment of diabetes and heart failure, Edouard Fu – however – highlights that initial clinical trials on the effectiveness and safety of SGLT2 inhibitors do not portray the whole picture quite yet. “These trials included very selective patient populations and their study size and duration is often not sufficient to investigate rare – but potentially serious safety outcomes. By applying cutting-edge statistical methods to big data of more than 200 million patients, we will be able to investigate the effectiveness and safety of these drugs in patients with diabetes and heart failure in a real-life setting.”
This WINNER (Week of Indonesia Netherlands Education and Research) event is a follow-up of the Climate Adaptation Summit (CAS), January 2021, and explores forms of cooperation between and within nations to make climate adaptation work for everyone, with a focus on Indonesia and the Netherlands. We will build on the successful international establishment of the Adaptation Action Agenda with high level keynotes. Then, two forms of Indonesia – Netherlands collaboration in urban and rural areas will be highlighted. Finally, we dive into the prerequisites for successful climate adaptation in a session focused on a priority for both the Netherlands and Indonesia: water resilience.
Today’s health care system faces many challenges. The new interdisciplinary two years master PHM will train you to contribute to a more integrated health care system.
Health care faces ageing populations, rising health care costs, fragmented health care supply and advancing medical technologies and IT systems. Health care professionals will require new competences to meet these challenges in the current health care system. Population Health Management (PHM) is a broadly based response to the challenges and has emerged worldwide as an important strategy for health care
Artificial Intelligence (AI) is one of those hot topics that we all talk about, but at the same time we have a hard time grasping what AI really is and how it is implemented in our daily lives. And understandably so, AI is a very complex and extensive topic. Needless to say, implementing AI models is difficult, because so many (ethical) variables play a role for a successful, acceptable, and most of all beneficial implementation. It’s one of the most interesting fields to study and that’s exactly what LUMC PhD candidates Marieke van Buchem and Anne de Hond are doing, so that they can contribute to better validation and implementation of AI models in medical care. Their exchange to Stanford University helps them move forward with their research.